Mortality by baseline CD4 cell count among HIV patients initiating antiretroviral therapy: evidence from a large cohort in Uganda

Hdl Handle:
http://hdl.handle.net/10144/249796
Title:
Mortality by baseline CD4 cell count among HIV patients initiating antiretroviral therapy: evidence from a large cohort in Uganda
Authors:
Mills, Edward J; Bakanda, Celestin; Birungi, Josephine; Mwesigwa, Robert; Chan, Keith; Ford, Nathan; Hogg, Robert S; Cooper, Curtis
Journal:
AIDS (London, England)
Abstract:
Evaluations of CD4 cell count and other prognostic factors on the survival of HIV patients in sub-Saharan Africa are extremely limited. Funders have been reticent to recommend earlier initiation of treatment. We aimed to examine the effect of baseline CD4 cell count on mortality using data from HIV patients receiving combination antiretroviral therapy (cART) in Uganda.
Affiliation:
Faculty of Health Sciences, University of Ottawa, Ottawa, Canada; The AIDS Support Organization (TASO), Headquarters, Kampala, Uganda; British Columbia Centre for Excellence in HIV/AIDS, Vancouver, Canada; Médecins Sans Frontiers (MSF), Geneva, Switzerland; Division of Infectious Diseases, The Ottawa Hospital, Ottawa, Canada
Publisher:
Lippincott Williams & Wilkins
Issue Date:
27-Mar-2011
URI:
http://hdl.handle.net/10144/249796
DOI:
10.1097/QAD.0b013e32834564e9
PubMed ID:
21330903
Additional Links:
http://journals.lww.com/aidsonline/Abstract/2011/03270/Mortality_by_baseline_CD4_cell_count_among_HIV.16.aspx
Type:
Article
Language:
en
ISSN:
1473-5571
Appears in Collections:
HIV/AIDS

Full metadata record

DC FieldValue Language
dc.contributor.authorMills, Edward Jen_GB
dc.contributor.authorBakanda, Celestinen_GB
dc.contributor.authorBirungi, Josephineen_GB
dc.contributor.authorMwesigwa, Roberten_GB
dc.contributor.authorChan, Keithen_GB
dc.contributor.authorFord, Nathanen_GB
dc.contributor.authorHogg, Robert Sen_GB
dc.contributor.authorCooper, Curtisen_GB
dc.date.accessioned2012-10-22T16:14:16Z-
dc.date.available2012-10-22T16:14:16Z-
dc.date.issued2011-03-27-
dc.identifier.citationAIDS 2011; 25(6):851-5en_GB
dc.identifier.issn1473-5571-
dc.identifier.pmid21330903-
dc.identifier.doi10.1097/QAD.0b013e32834564e9-
dc.identifier.urihttp://hdl.handle.net/10144/249796-
dc.description.abstractEvaluations of CD4 cell count and other prognostic factors on the survival of HIV patients in sub-Saharan Africa are extremely limited. Funders have been reticent to recommend earlier initiation of treatment. We aimed to examine the effect of baseline CD4 cell count on mortality using data from HIV patients receiving combination antiretroviral therapy (cART) in Uganda.en_GB
dc.language.isoenen
dc.publisherLippincott Williams & Wilkinsen_GB
dc.relation.urlhttp://journals.lww.com/aidsonline/Abstract/2011/03270/Mortality_by_baseline_CD4_cell_count_among_HIV.16.aspxen_GB
dc.rightsPublished by Wolters Kluwer Lippincott Williams & Wilkins - Archived on this site by kind permission Wolters Kluweren_GB
dc.subject.meshAdulten_GB
dc.subject.meshAnti-Retroviral Agentsen_GB
dc.subject.meshCD4 Lymphocyte Counten_GB
dc.subject.meshCohort Studiesen_GB
dc.subject.meshFemaleen_GB
dc.subject.meshHIV Infectionsen_GB
dc.subject.meshHIV-1en_GB
dc.subject.meshHumansen_GB
dc.subject.meshMaleen_GB
dc.subject.meshUgandaen_GB
dc.subject.meshViral Loaden_GB
dc.titleMortality by baseline CD4 cell count among HIV patients initiating antiretroviral therapy: evidence from a large cohort in Ugandaen
dc.typeArticleen
dc.contributor.departmentFaculty of Health Sciences, University of Ottawa, Ottawa, Canada; The AIDS Support Organization (TASO), Headquarters, Kampala, Uganda; British Columbia Centre for Excellence in HIV/AIDS, Vancouver, Canada; Médecins Sans Frontiers (MSF), Geneva, Switzerland; Division of Infectious Diseases, The Ottawa Hospital, Ottawa, Canadaen_GB
dc.identifier.journalAIDS (London, England)en_GB

Related articles on PubMed

All Items in MSF are protected by copyright, with all rights reserved, unless otherwise indicated.